SAGE
Price
$19.73
Change
+$0.25 (+1.28%)
Updated
Nov 30, 3:11 PM EST
84 days until earnings call
TYRA
Price
$11.06
Change
+$0.01 (+0.09%)
Updated
Nov 30, 2:23 PM EST
91 days until earnings call
Ad is loading...

Compare predictions SAGE vs TYRA

Header iconSAGE vs TYRA Comparison
Open Charts SAGE vs TYRABanner chart's image
Sage Therapeutics
Price$19.73
Change+$0.25 (+1.28%)
Volume$100
CapitalizationN/A
Tyra Biosciences
Price$11.06
Change+$0.01 (+0.09%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
SAGE vs TYRA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
SAGE vs. TYRA commentary
Nov 30, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGE is a StrongBuy and TYRA is a Hold.

COMPARISON
Comparison
Nov 30, 2023
Stock price -- (SAGE: $19.48 vs. TYRA: $11.05)
Brand notoriety: SAGE and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SAGE: 76% vs. TYRA: 124%
Market capitalization -- SAGE: $1.15B vs. TYRA: $482.69M
SAGE [@Biotechnology] is valued at $1.15B. TYRA’s [@Biotechnology] market capitalization is $482.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SAGE’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • SAGE’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAGE’s TA Score shows that 4 TA indicator(s) are bullish while TYRA’s TA Score has 4 bullish TA indicator(s).

  • SAGE’s TA Score: 4 bullish, 4 bearish.
  • TYRA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TYRA is a better buy in the short-term than SAGE.

Price Growth

SAGE (@Biotechnology) experienced а +0.26% price change this week, while TYRA (@Biotechnology) price change was -3.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +28.60%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

SAGE is expected to report earnings on Feb 22, 2024.

TYRA is expected to report earnings on Feb 29, 2024.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SAGE with price predictions.
OPEN
A.I.dvisor published
a Summary for TYRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SAGE($1.15B) has a higher market cap than TYRA($483M). TYRA has higher P/E ratio than SAGE: TYRA (21.79) vs SAGE (2.85). TYRA YTD gains are higher at: 45.395 vs. SAGE (-48.925). TYRA has higher annual earnings (EBITDA): -69M vs. SAGE (-656.8M). SAGE has more cash in the bank: 876M vs. TYRA (216M). TYRA has less debt than SAGE: TYRA (6.11M) vs SAGE (6.97M). SAGE has higher revenues than TYRA: SAGE (11.3M) vs TYRA (0).
SAGETYRASAGE / TYRA
Capitalization1.15B483M237%
EBITDA-656.8M-69M952%
Gain YTD-48.92545.395-108%
P/E Ratio2.8521.7913%
Revenue11.3M0-
Total Cash876M216M406%
Total Debt6.97M6.11M114%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SAGETYRA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
72%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSDX15.360.14
+0.92%
MainStay Fiera SMID Growth R6
MQRIX13.930.09
+0.65%
ACR Multi-Strategy Quality Ret (MQR) I
MXREX10.86N/A
N/A
Empower Real Estate Index Inv
BBVLX15.87N/A
N/A
Bridge Builder Large Cap Value
FIQOX29.93-0.09
-0.30%
Fidelity Advisor® Worldwide Z

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with ORMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-2.13%
ORMP - TYRA
38%
Loosely correlated
+1.38%
SRNEQ - TYRA
36%
Loosely correlated
-8.54%
BBIO - TYRA
34%
Loosely correlated
-1.28%
XNCR - TYRA
32%
Poorly correlated
-2.08%
SAGE - TYRA
32%
Poorly correlated
+1.09%
More